Increased transgenic egg production and staffing of new operations among its New Vietnamese Subsidiary’s next steps

ANN ARBOR, Mich., – May 14, 2018 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers provides an update on progress towards the commercialization of spider silk technology following last week’s announcement of the formation of its Vietnamese subsidiary, Prodigy Textiles Co,. Ltd (“Prodigy”).  The Company views Prodigy as its main production arm for spider silk technologies.

The Company is gearing up production of its proprietary spider silk silkworm eggs in preparation for shipment to Prodigy.  These Silkworms are slated to be the first transgenics produced at Prodigy.

Kraig Labs has identified a facility, in Quang Nam province, with the capacity to support operations and is working with local experts to update and buildout the facility to meet production specifications.    

To bring Prodigy production operations online, Kraig Labs has accelerated Prodigy’s staffing and hiring plans.  Key technical and administration positions within Prodigy have been identified and the Company is working with its consultants in Vietnam to fill these positions. 

Company management is now preparing to travel to Vietnam to oversee Prodigy’s launch, where they will also be oversee hiring core staff, the transfer of the Company’s spider silk silkworm technology, and the beginning of operations. 

“Momentum at Prodigy is growing and we’re focused on the exciting milestones ahead,” said Jon Rice, COO.  “We are busy preparing silkworm eggs for shipment and putting the team in place at Prodigy to hit the ground running.  We are now taking concrete steps to build on all the work we’ve done in Vietnam and to convert that into a thriving operation for spider silk production.”

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

Dear Shareholders,

There have been a number of request for a supplement to the last issue of spider sense regarding our progress towards obtaining an enterprise registration certificate, or equivalent in Vietnam.  The Enterprise Registration Certificate (ERC) is effectively our business license to conduct our operations in Vietnam. 

It’s an important subject, as Vietnam is one of the countries with the existing infrastructure to support mass production of our spider silk.  Existing silkworm infrastructure should translate into superior quality and great cost reductions, compared to building out from scratch at shareholder expense.  For these reasons we view our discussions with officials in silk producing countries, including those in Vietnam, as being critical for our commercialization efforts. 

That being said, negotiations with high level government offices are often challenging, with multiple competing interests vying for influence.  These challenges exist in any bureaucracy.   Over the last twelve months, the Company, and its consultants in Vietnam, held a series of successful meetings with top officials within central government and provincial offices.   Each of these meetings moved our project forward.  This forward progress was not without contention from some individuals within the bureaucracy.   That, as you can appreciate, is how governmental systems work. These meetings have brought us closer to our goal.

We have assembled the right team of people in Vietnam working within the provinces and at the central government level to see this process to successfully completion.  In parallel with working to secure our ERC, or equivalent authorization, we are working with provincial officials and our consultants in Vietnam to identify local staff and facilities.   

Recent questions surrounding news stories, translated from the original Vietnamese sources, highlight the challenges of working across languages and with large government agencies.  Different offices within the bureaucracy have different priorities and this leads to the contentious nature of some of these meetings. 

Those article have described some of the more touchy elements of those meetings, while excluding key portions and conclusions.  The Company has made significant progress over the last six months.  We believe that we are on track for international production and that the process in Vietnam in particular is coming to ahead.      

While operations in a major silk producing country remain a key element of the Company’s growth plan, it is not our only approach.  In 2017, we made two major moves to expand our domestic operations.  In the first quarter, we leased 15 acres of land in Texas and planted our first 2,000 mulberry trees.  In the fourth quarter, we opened a new production and research headquarters in Michigan, more than tripling our floor plan and capacity.  Combined, these two domestic facilities represent a significant increase in our domestic capacity. 

Our approach to developing and producing spider silk leverages nature’s silk factory, the silkworm.  This approach is driven by; molecular biology, process simplicity, cost benefits, and competitive advantage.   The infrastructure, tools, and skills, to produce high quality silk, already exist.  We are certain that our cost effective approach, combined with leveraging existing infrastructure, are key to seeing this market grow into the thriving disruptive technology it has the potential to become. 

We do believe that we have the greatest and most enthusiastic group of shareholders that any company could ask for and we thank all of you for your continued support and even for your occasional criticism.  You are appreciated.

Thank you. 

Kim Thompson                                  Jon Rice
CEO                                                        COO

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could”, “spectacular”, “dramatic”, or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This letter does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -May 19, 2017- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has delivered the first samples of Dragon Silk to the US Army for independent testing.  The Company provided several samples of individual silk filaments as well as finished Dragon Silk thread for evaluation.

“We are pleased to report that we have delivered the first samples of Dragon Silk to our US Army sponsor for independent performance confirmation,” said the Company’s COO Jon Rice.  “These samples mark the starting point for what we hope will be a long lasting and profound impact on protective equipment for those dedicated to protecting us.  The speed that our Indiana facility was able to ramp up to meet this request helps to confirm, that we have the ability to promptly deliver a top quality, cost effective, fiber to the Army and future commercial customers.”

The Company is producing Dragon Silk at its Indiana factory and expects to make final delivery of the shoot packs for ballistic testing later this year.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

ANN ARBOR, Mich., -December 19, 2016- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it completed the first batch of Dragon Silk™ cocoon production for its recently reported military contract.  The fibers will soon be headed to a reeling facility to be prepared for delivery to Warwick Mills.

The Company will contract Warwick Mills to produce ballistic shoot packs, for delivery to the US Army, based on the Company’s Dragon Silk technology.  The Company expected to make final delivery to the US Army in the second quarter of 2017.

“The Indiana factory scale up of our proprietary recombinant spider silk, we call Dragon silk, has exceeded our expectations.  As we ship this first batch of Dragon Silk cocoons dedicated for the US Army, we are already beginning to prepare for production of fibers ready for commercial sale to some of our primary end users,” said Company Founder and CEO Kim Thompson. 

The Company will now begin to sell its Dragon Silk and Monster Silk fibers, in earnest, to the various parties that have submitted sample requests, with priority given to substantive collaborative development agreements and key end uses.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.kraiglabs.com/newsletter.

For more information about Spider Silk, check it out at www.kraiglabs.com/spider-silk.

About Warwick Mills

For the past century, Warwick Mills has been a leader in the engineering of technical textiles for protective applications. Warwick develops and integrates complex fiber composites for the most challenging safety applications. Its cooperative development strategy relies on its core technologies in technical textiles, custom adhesives, and performance coatings, from research and development to testing and full-scale manufacturing. This strategy ensures customer confidence for every challenge.

http://www.warwickmills.com

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

CEO and COO to discuss spider silk commercialization and corporate developments

ANN ARBOR, Mich., – November 30, 2015 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announces a conference call to be hosted by Kim Thompson and Jon Rice on Friday, December 4, 2015 at 4:30 PM EST. The Company invites all shareholders and other interested parties to participate in the call.

Thompson, the Company’s CEO and Founder and Rice, the Company’s COO, will update shareholders on production, scientific milestones, commercialization strategy and corporate developments.  Following the Company progress update, Thompson and Rice will hold a questions and answer session moderated by Ben Hansel.  Shareholders are invited to submit question to IR@kraiglabs.com in advance of the call.

Interested parties are invited to dial the toll free number below.

1-866-906-9888 and when prompted, enter access code 9285926 followed by the # (pound) sign.

It is recommended that callers dial in approximately five minutes before the conference is scheduled to begin.

The Company anticipates posting a recording of the conference call on the Company website shortly after the call for interested parties who are unable to attend the call.

Conference call: 4:30 p.m. EST (Eastern Standard Time), Friday, December 4, 2015.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Kraig Biocraft Labs featured by Fibre2Fashion in an interview with Jon Rice, discussing the emerging spider silk industry and its possible applications.

http://www.fibre2fashion.com/face2face/kraig-biocraft-laboratories/jon-rice.asp

The Company did not draft the content of this article and the link do not constitute an endorsement by the Company of such content. The Company does not control the content or information contained in this link or website. The information on such websites has not been verified by Kraig Biocraft Laboratories. The viewer should use caution and prudence when viewing such information

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Future Materials Magazine discussed Kraig’s technology and business model developments in cover story titled “Web of Knowledge, Realizing Commercial Possibilities for Spider Silk”

ANN ARBOR, Mich., – September 30, 2015- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced today that Future Materials Magazine is featuring the Company in an article titled “Strong as Silk”, as well as on the magazine’s cover.

The feature may be accessed at the following link; http://www.textilemagazines.com/Future_Materials/Issue_5_2015/0958140815/index.htmlThe article “Strong as Silk” begins on page 17.

“The technical textile markets are enormous in size and scope. Though we believe we have identified several key users for our products, this type of exposure is vital to expanding our audience.  It’s a great honor to be featured in this edition of Future Materials Magazine.  The magazine’s geographic and industry footprint provides us a combination of additional publicity and potential product development opportunities,” said Kraig COO, Jon Rice.

“We are thrilled to receive coverage in this edition of Future Materials Magazine, which reaches many of our relevant audiences around the world,” said Kraig CEO and founder, Kim K. Thompson.  “Our genetically engineered spider silk is an amazing material and it is rewarding to see it recognized in Future Materials Magazine.”

Future Materials is published by the World Textile Information Network (WTiN).  Established more than 100 years ago, WTiN is a world leading textile news and information provider. WTiN’s magazines & Online Products (WTiN Intelligence, Textile Cost Manager, Textile Database) – have long been recognized for their authority and market-leading coverage.

For more information regarding WTiN go to: www.WTiN.com

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com

Internationale Textilmaschinen Ausstellung recognizes Kraig in “Most innovative small company”, “Best innovation – protective textiles” and “Best innovation – sustainable textiles” Classifications

ANN ARBOR, Mich., – September 22, 2015 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced today that the Company was named as a finalist in three categories for Internationale Textilmaschinen Ausstellung’s (“ITMA”) Future Materials Awards 2015.

“I would like to thank ITMA, the world’s largest international textile machinery exhibition, for recognizing our technology and efforts, and congratulate the other finalists for making the shortlist.  We are excited to once again be recognized by the ITMA for our technology and our contributions to the industry.  I believe that the recognition by the ITMA for the ‘Most innovative small company’, ‘Best innovation, protective textile’, and ‘Best innovation, sustainable textile’ categories is a testament to the continued effort of our team, our technology and our shareholders.  We look forward to the announcement of the winners in November,” said Kraig CEO and founder, Kim K. Thompson.

“We are grateful for the recognition by ITMA of our successes and the investments of our team and our shareholders in creating high performance, sustainable, petroleum-free fibers.  Our team continues to demonstrate that it is possible to deliver best in class material performance without compromising environmental responsibility.  I am honored to be part of this legacy of work and its impact on the textile industry,” said Kraig COO, Jon Rice.

Further ITMA Future Materials Awards 2015 information can be viewed at the following link:www.futurematerialsawards.com

Further ITMA information can be viewed at the following link: www.cematex.com/whatisitma.cfm

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC.

(720) 288-8495

ir@KraigLabs.com